Methanol Chemicals Company (2001) Q2 2026 earnings summary

Executive summary

• Reported a net loss of 84.6 million for the six-month period ended June 30, 2026, a significant improvement from a 439.7 million loss in the prior year period.

• Revenue for the six months was 272.3 million, down from 315.6 million year-over-year, mainly due to adverse economic and geopolitical factors.

• Accumulated losses exceeded half of share capital, triggering regulatory requirements for capital restructuring.

• Extraordinary General Assembly approved a capital reduction and partial utilization of statutory reserves to eliminate accumulated losses.

Financial highlights

• Revenue for H1 2026: 272.3 million (down from 315.6 million in H1 2025).

• Gross profit for H1 2026: 18.3 million (down from 12.0 million in H1 2025).

• Net loss for H1 2026: 84.6 million (improved from 439.7 million loss in H1 2025).

• Basic and diluted loss per share for H1 2026: (1.21) vs. (5.66) in H1 2025.

• Cash and cash equivalents at June 30, 2026: 94.0 million.

Outlook and guidance

• Management expects ongoing operational improvements and cost optimization to support liquidity.

• Successful completion of capital reduction and rights issue in Q4 2026 is critical for financial stability.

• Geopolitical instability and market volatility remain key uncertainties for future performance.